| Lupin Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Particulars | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 | Mar '2020 |
|---|---|---|---|---|---|
| Debt-Equity Ratio | 0.02 | 0.05 | 0.04 | 0.01 | 0.00 |
| Long Term Debt-Equity Ratio | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| Current Ratio | 1.98 | 1.93 | 2.28 | 2.79 | 3.05 |
| Fixed Assets | 1.95 | 1.60 | 1.82 | 1.86 | 2.11 |
| Inventory | 4.90 | 3.63 | 4.00 | 4.26 | 4.60 |
| Debtors | 4.50 | 4.17 | 3.98 | 3.25 | 3.00 |
| Interest Cover Ratio | 50.42 | 6.35 | -1.62 | 41.12 | 33.45 |
| PBIDTM (%) | 24.31 | 10.43 | 3.36 | 19.66 | 20.66 |
| PBITM (%) | 19.37 | 5.56 | -1.01 | 15.11 | 15.96 |
| PBDTM (%) | 23.93 | 9.55 | 2.74 | 19.29 | 20.18 |
| CPM (%) | 20.80 | 8.65 | 2.50 | 15.93 | 15.16 |
| APATM (%) | 15.86 | 3.78 | -1.86 | 11.38 | 10.46 |
| ROCE (%) | 13.96 | 3.21 | -0.61 | 8.95 | 9.95 |
| RONW (%) | 11.92 | 2.33 | -1.19 | 6.98 | 6.67 |